BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18402552)

  • 1. Hepatocyte growth factor activator inhibitor-1 has a complex subcellular itinerary.
    Godiksen S; Selzer-Plon J; Pedersen ED; Abell K; Rasmussen HB; Szabo R; Bugge TH; Vogel LK
    Biochem J; 2008 Jul; 413(2):251-9. PubMed ID: 18402552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase.
    Larsen BR; Steffensen SD; Nielsen NV; Friis S; Godiksen S; Bornholdt J; Soendergaard C; Nonboe AW; Andersen MN; Poulsen SS; Szabo R; Bugge TH; Lin CY; Skovbjerg H; Jensen JK; Vogel LK
    Exp Cell Res; 2013 Apr; 319(6):918-29. PubMed ID: 23333561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transport via the transcytotic pathway makes prostasin available as a substrate for matriptase.
    Friis S; Godiksen S; Bornholdt J; Selzer-Plon J; Rasmussen HB; Bugge TH; Lin CY; Vogel LK
    J Biol Chem; 2011 Feb; 286(7):5793-802. PubMed ID: 21148558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.
    Szabo R; Hobson JP; List K; Molinolo A; Lin CY; Bugge TH
    J Biol Chem; 2008 Oct; 283(43):29495-504. PubMed ID: 18713750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential subcellular localization renders HAI-2 a matriptase inhibitor in breast cancer cells but not in mammary epithelial cells.
    Chang HH; Xu Y; Lai H; Yang X; Tseng CC; Lai YJ; Pan Y; Zhou E; Johnson MD; Wang JK; Lin CY
    PLoS One; 2015; 10(3):e0120489. PubMed ID: 25786220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intracellular seven amino acid motif EEGEVFL is required for matriptase vesicle sorting and translocation to the basolateral plasma membrane.
    Tseng CC; Jia B; Barndt RB; Dai YH; Chen YH; Du PA; Wang JK; Tang HJ; Lin CY; Johnson MD
    PLoS One; 2020; 15(2):e0228874. PubMed ID: 32049977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.
    Friis S; Sales KU; Schafer JM; Vogel LK; Kataoka H; Bugge TH
    J Biol Chem; 2014 Aug; 289(32):22319-32. PubMed ID: 24962579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition.
    Wang JK; Lee MS; Tseng IC; Chou FP; Chen YW; Fulton A; Lee HS; Chen CJ; Johnson MD; Lin CY
    Am J Physiol Cell Physiol; 2009 Aug; 297(2):C459-70. PubMed ID: 19535514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of an active zymogen protease: the zymogen form of matriptase is regulated by HAI-1 and HAI-2.
    Skovbjerg S; Holt-Danborg L; Nonboe AW; Hong Z; Frost ÁK; Schar CR; Thomas CC; Vitved L; Jensen JK; Vogel LK
    Biochem J; 2020 May; 477(9):1779-1794. PubMed ID: 32338287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development.
    Szabo R; Molinolo A; List K; Bugge TH
    Oncogene; 2007 Mar; 26(11):1546-56. PubMed ID: 16983341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matriptase Complexes and Prostasin Complexes with HAI-1 and HAI-2 in Human Milk: Significant Proteolysis in Lactation.
    Lai CH; Lai YJ; Chou FP; Chang HH; Tseng CC; Johnson MD; Wang JK; Lin CY
    PLoS One; 2016; 11(4):e0152904. PubMed ID: 27043831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein.
    Mitchell AC; Kannan D; Hunter SA; Parra Sperberg RA; Chang CH; Cochran JR
    J Biol Chem; 2018 Apr; 293(14):4969-4980. PubMed ID: 29386351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease.
    Oberst MD; Chen LY; Kiyomiya K; Williams CA; Lee MS; Johnson MD; Dickson RB; Lin CY
    Am J Physiol Cell Physiol; 2005 Aug; 289(2):C462-70. PubMed ID: 15800053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1.
    Kirchhofer D; Peek M; Li W; Stamos J; Eigenbrot C; Kadkhodayan S; Elliott JM; Corpuz RT; Lazarus RA; Moran P
    J Biol Chem; 2003 Sep; 278(38):36341-9. PubMed ID: 12815039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase.
    Kojima K; Tsuzuki S; Fushiki T; Inouye K
    J Biol Chem; 2008 Feb; 283(5):2478-87. PubMed ID: 18048349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor activator inhibitor type 1 inhibits protease activity and proteolytic activation of human airway trypsin-like protease.
    Kato M; Hashimoto T; Shimomura T; Kataoka H; Ohi H; Kitamura N
    J Biochem; 2012 Feb; 151(2):179-87. PubMed ID: 22023801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells.
    Lee MS; Kiyomiya K; Benaud C; Dickson RB; Lin CY
    Am J Physiol Cell Physiol; 2005 Apr; 288(4):C932-41. PubMed ID: 15590895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation.
    Szabo R; Uzzun Sales K; Kosa P; Shylo NA; Godiksen S; Hansen KK; Friis S; Gutkind JS; Vogel LK; Hummler E; Camerer E; Bugge TH
    PLoS Genet; 2012; 8(8):e1002937. PubMed ID: 22952456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Inhibition of Prostasin in Human Enterocytes by the Integral Membrane Kunitz-Type Serine Protease Inhibitor HAI-2.
    Shiao F; Liu LO; Huang N; Lai YJ; Barndt RJ; Tseng CC; Wang JK; Jia B; Johnson MD; Lin CY
    PLoS One; 2017; 12(1):e0170944. PubMed ID: 28125689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1.
    Denda K; Shimomura T; Kawaguchi T; Miyazawa K; Kitamura N
    J Biol Chem; 2002 Apr; 277(16):14053-9. PubMed ID: 11805118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.